Atai Beckley, Inc. (ATAI)
7.34
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
7.35
+0.01
(+0.14%)
After-Hours: 20:00
Atai Beckley Research and Development Expense (Annual) : 53.06M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 53.06M |
| December 31, 2024 | 54.98M |
| December 31, 2023 | 61.88M |
| December 31, 2022 | 74.14M |
| Date | Value |
|---|---|
| December 31, 2021 | 47.91M |
| December 31, 2020 | 23.43M |
| December 31, 2019 | 12.76M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| GH Research Plc | 38.73M |
| Johnson & Johnson | 14.83B |
| Merck & Co., Inc. | 12.51B |
| Zoetis, Inc. | 698.00M |